Scoot's departureScott Spearn was never been touted as the be all and end all. Scott has a family issue which he felt was in need of all of his attention.
MedX has given guidance to expect revenue from the new platform starting in Q2 and building in Q3-4 how you determined there is no revenue when MedX hasn't reported is beyond my comprehension. MedX just partnered in Mexico which if you read the announcement carefully you woul discover has a huge issue with melanoma because of awareness and the late stage when melanomas are discovered. 120 million population market. I would suggest to watch the Agoracom video as it gives great clarity in where MedX is positioned currently.
MedX just completed a successful financing and has hired additional sales execs to the team. The writing on the wall is, MedX is in the best place it has ever been. Robert vonder Porten stepping into the role of CEO will be seamless as he was the previous President and CEO so in the immortal words of Shakespeare "Much Ado about Nothing".